ArticleCancer gene therapy2025

Combined downregulation of TGF-β1 and GRP78 is responsible for overcoming acquired sorafenib resistance, which is initiated by rewiring the cell surface CD44-GRP78-IGF-1R signaling circuit.

Shengji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.